We are live on ! Find out more
BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $1.11B
1-Year Est. Return 171.34%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+171.34%
3 Year Est. Return
+643.23%
5 Year Est. Return
+451.99%
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$17.2M
Cap. Flow
+$44.8M
Cap. Flow %
26.41%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$44.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 40.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$85.4M 50.34%
8,930,237
– –
IFRX icon
2
InflaRx
IFRX
$271M
$54.1M 31.91%
1,876,413
– –
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.2M 8.96%
994,363
– –
SLDB icon
4
Solid Biosciences
SLDB
$900M
$14.9M 8.8%
+132,630
New +$44.8M

Similar funds

SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
JTWM
Jackson Thornton Wealth Management Montgomery, Alabama $1.11B AUM 22.53% 1-Year Est. Return
RWM
RKL Wealth Management Lancaster, Pennsylvania $1.11B AUM 18.99% 1-Year Est. Return
EIA
Emerald Investment Advisers Leola, Pennsylvania $1.11B AUM
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Bain Capital Life Sciences Investors's Q1 2018 Portfolio in Review

As of Q1 2018, Bain Capital Life Sciences Investors held 4 positions worth $170M, up 11% from $152M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Bain Capital Life Sciences Investors deployed $44.8M of net new capital in Q1 2018, opening 1 new position. Its largest new stake was Solid Biosciences: 132,630 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 26% a quarter earlier.

  • Bain Capital Life Sciences Investors's largest Q1 2018 buy was Solid Biosciences: 132,630 shares worth $14.9M.
  • Bain Capital Life Sciences Investors's ten largest holdings make up 100% of its $170M portfolio in Q1 2018.
  • Bain Capital Life Sciences Investors opened 1 new position and closed 0 in Q1 2018.
  • Bain Capital Life Sciences Investors's portfolio value rose 11% quarter-over-quarter to $170M.

Based on Bain Capital Life Sciences Investors's 13F filing for Q1 2018, filed 15 May 2018.